JNJ May 2024 150.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:58PM EDT. Market open.
| Previous Close | 4.2000 |
| Open | 4.9200 |
| Bid | 4.5000 |
| Ask | 4.7500 |
| Strike | 150.00 |
| Expire Date | 2024-05-24 |
| Day's Range | 3.9000 - 4.9200 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 705 |
ReutersJ&J-backed startup Rapport files for US IPO
Rapport, which develops small molecule medicines for patients suffering from central nervous system disorders, is gearing up for a listing as the IPO market recovers from a slump amid increasing hopes of a soft landing for the economy. The company said it will be selling shares in the IPO, but did not disclose how many nor the price range. Rapport's net loss widened to $34.8 million in 2023 from $10.7 million a year earlier.
ZacksJ&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Johnson & Johnson (JNJ) inks deal to acquire Proteologix, Inc. for $850 million in cash. The transaction is expected to be closed in mid-2024.
ZacksJohnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.